STOCK TITAN

Concentra grants Robert A. Ortenzio 3,989 shares

The director's reported holdings also include shares held through five named trusts.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Concentra Group Holdings Parent, Inc. director Robert A. Ortenzio acquired 3,989 shares of restricted stock on November 3, 2026. The award is scheduled to vest in full on November 3, 2027, subject to certain exceptions. His reported direct holdings after the award were 4,667,783 shares. Reported indirect holdings included 882,115 shares in the Robert A. Ortenzio Descendants Trust; 196,286 shares in each of the Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio and the Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio; 206,286 shares in the Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio; and 503,455 shares in the Rocco A. Ortenzio Separate Descendants Trust FBO Robert Ortenzio.

Insider ORTENZIO ROBERT A
Role Director
Type Security Shares Price Value
Grant/Award Common Stock F1 3,989 $0.00 $0.00
Holding Common Stock -- -- --
Holding Common Stock -- -- --
Holding Common Stock -- -- --
Holding Common Stock -- -- --
Holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 4,667,783 shares (Direct); Common Stock — 882,115 shares (Indirect, By the Robert A. Ortenzio Descendants Trust); Common Stock — 196,286 shares (Indirect, By the Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio); Common Stock — 196,286 shares (Indirect, By the Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio); Common Stock — 206,286 shares (Indirect, By the Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio); Common Stock — 503,455 shares (Indirect, The Rocco A. Ortenzio Separate Descendants Trust FBO Robert Ortenzio)
Holdings Before and After: Common Stock, 4,663,794 to 4,667,783 shares (Direct)
Footnotes (1)
  1. F1. Grant of restricted stock which, subject to certain exceptions, will vest in full on November 3, 2027, the first anniversary of the grant date.
Restricted stock award 3,989 shares Granted November 3, 2026
Direct common stock holdings 4,667,783 shares Following the November 3, 2026 transaction
Robert A. Ortenzio Descendants Trust common stock holdings 882,115 shares Reported November 3, 2026
Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio common stock holdings 196,286 shares Reported November 3, 2026
Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio common stock holdings 196,286 shares Reported November 3, 2026
Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio common stock holdings 206,286 shares Reported November 3, 2026
Rocco A. Ortenzio Separate Descendants Trust FBO Robert Ortenzio common stock holdings 503,455 shares Reported November 3, 2026
restricted stock financial
"Grant of restricted stock"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
vest in full financial
"will vest in full on November 3, 2027"
grant date financial
"the first anniversary of the grant date"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares of CON restricted stock did Robert A. Ortenzio receive?

Robert A. Ortenzio received 3,989 shares of restricted stock on November 3, 2026. The award is scheduled to vest in full on November 3, 2027, subject to certain exceptions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ORTENZIO ROBERT A

(Last)(First)(Middle)
C/O CONCENTRA GROUP HOLDINGS PARENT, INC
5080 SPECTRUM DRIVE, SUITE 1200W

(Street)
ADDISON TEXAS 75001

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Concentra Group Holdings Parent, Inc. [ CON ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/03/2026A(1)3,989A$04,667,783D
Common Stock882,115IBy the Robert A. Ortenzio Descendants Trust
Common Stock196,286IBy the Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio
Common Stock196,286IBy the Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio
Common Stock206,286IBy the Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio
Common Stock503,455IThe Rocco A. Ortenzio Separate Descendants Trust FBO Robert Ortenzio
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Grant of restricted stock which, subject to certain exceptions, will vest in full on November 3, 2027, the first anniversary of the grant date.
Remarks:
/s/ Timothy F. Ryan, Attorney-in-Fact11/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading